PAREXEL Intl Corp. (PRXL)

1 member of Congress has disclosed 5 trades in PAREXEL Intl Corp. (PRXL) via STOCK Act filings. The most recent disclosure was a sale by Pete Sessions on 21 December 2016. Aggregate disclosed activity totals roughly $65K in purchases and $97.5K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for PRXL
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for PRXL

5 transactions
Compliance: 20%
Pete Sessions21 Dec 201623 Dec 2016SaleStock$15,001 - $50,000N/A
Pete Sessions21 Dec 201615 May 2017SaleStock$15,001 - $50,000N/A
Pete Sessions21 Dec 201610 May 2018SaleStock$15,001 - $50,000N/A
Pete Sessions29 Jan 201615 May 2017PurchaseStock$15,001 - $50,000N/A
Pete Sessions29 Jan 201610 May 2018PurchaseStock$15,001 - $50,000N/A

Stock Overview

Market Data

Market Cap

$0

Volume

7.02M

Beta

0.76

P/E Ratio

42.97

Fundamentals

EPS

$2.05

Div. Yield

-

Open

$88.10

Day Range

$88.07 – $88.10

Company Information

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ · USD
IPO Date
1995-11-22

Earnings

Recent Quarters

Q1 20178 May
EPS$0.34
Q4 20169 Feb
EPS$0.42
Q3 201614 Nov
EPS$0.71
Q2 201630 Sept
EPS$0.58
Q4 20152 Feb
EPS$0.73
Q2 201530 Sept
EPS$0.80
Q1 201530 Jun
EPS$0.89
Q3 201431 Dec
EPS$0.45
Q2 201430 Sept
EPS$0.62
Q1 201430 Jun
EPS$0.69
Q4 201331 Mar
EPS$0.71
Q3 201331 Dec
EPS$0.68
Q2 201330 Sept
EPS$0.71
Q1 201330 Jun
EPS$0.61
Q4 201231 Mar
EPS$0.50
Q3 201231 Dec
EPS$0.46
Q2 201230 Sept
EPS$0.51
Q1 201230 Jun
EPS$0.50
Q4 201131 Mar
EPS$0.36
Q3 201131 Dec
EPS$0.25
Q2 201130 Sept
EPS$0.30
Q1 201130 Jun
EPS$0.39
Q4 201031 Mar
EPS$0.22
Q3 201031 Dec
EPS$0.16
Q2 201030 Sept
EPS$-0.03
Q1 201030 Jun
EPS$0.27
Q4 200931 Mar
EPS$0.29
Q3 200931 Dec
EPS$0.30
Q2 200930 Sept
EPS$0.22
Q1 200930 Jun
EPS$0.22
Q4 200831 Mar
EPS$0.06
Q3 200831 Dec
EPS$0.22
Q2 200830 Sept
EPS$0.11
Q1 200830 Jun
EPS$0.25
Q4 200731 Mar
EPS$0.09
Q3 200731 Dec
EPS$0.24
Q2 200730 Sept
EPS$0.45
Q1 200730 Jun
EPS$0.25
Q4 200631 Mar
EPS$0.42
Q3 200631 Dec
EPS$0.50
Q3 20069 Nov
EPS$0.26
Q2 200630 Sept
EPS$0.38
Q2 20068 Sept
EPS$0.32
Q1 200630 Jun
EPS$0.40
Q1 20069 May
EPS$0.26
Q4 200531 Mar
EPS$0.33

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about PRXL

Which members of Congress have traded PRXL?
1 member of Congress has disclosed 5 trade in PAREXEL Intl Corp. (PRXL) under the STOCK Act: Pete Sessions.
When was PRXL most recently disclosed by Congress?
The most recent PRXL disclosure was a sale by Pete Sessions on 21 December 2016.
What is the total disclosed congressional trading volume for PRXL?
Members of Congress have disclosed approximately $65K in PRXL purchases and $97.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in PRXL?
This PRXL page updates as soon as new STOCK Act disclosures are filed for PAREXEL Intl Corp.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.